Advertisement
Canada markets open in 5 hours 23 minutes
  • S&P/TSX

    22,107.08
    +194.56 (+0.89%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CAD/USD

    0.7355
    -0.0018 (-0.24%)
     
  • CRUDE OIL

    81.79
    +0.44 (+0.54%)
     
  • Bitcoin CAD

    95,703.06
    +739.98 (+0.78%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,214.40
    +1.70 (+0.08%)
     
  • RUSSELL 2000

    2,114.35
    +44.19 (+2.13%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • NASDAQ futures

    18,503.25
    -0.50 (-0.00%)
     
  • VOLATILITY

    12.95
    +0.17 (+1.33%)
     
  • FTSE

    7,931.98
    0.00 (0.00%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6810
    +0.0005 (+0.07%)
     

J-K LG Sinha appeals to beneficiaries to get vaccinated against COVID-19

Jammu and Kashmir Lieutenant Governor Manoj Sinha.
Jammu and Kashmir Lieutenant Governor Manoj Sinha.

Jammu (Jammu and Kashmir) [India], January 20 (ANI): Jammu and Kashmir Lieutenant Governor Manoj Sinha on Wednesday appealed to beneficiaries to get themselves vaccinated by COVID-19 vaccines, amid apprehensions of their efficacy.

"There is a need to spread awareness about the vaccine. Both the COVID-19 vaccines were given emergency use approval only after scientists were convinced of their safety. I appeal to all beneficiaries to get themselves vaccinated," said LG Sinha.

Billed as the world's largest vaccination program, covering the entire length and breadth of the country, the COVID-19 vaccination drive which began on January 16 aims to first vaccinate millions of its healthcare and frontline workers and reach an estimated 3 crore people by the end of its first phase.

The central government has introduced an application named CoWIN (Covid Vaccine Intelligence Work) to monitor the entire vaccination process. Two vaccines--Covaxin and Covishield-- have received Emergency Use Authorisation (EAU) after going through established safety and immunogenicity in a well-prescribed regulatory process and these will be administered during the vaccination drive. (ANI)